TABLE 2.
Disease | Transmission | Cyanosis | Anemia | Other symptoms | Gene(s) | MetHb level % | CYB5R activity | Hb electrophoresis/HPLC |
---|---|---|---|---|---|---|---|---|
Drug exposure | Acquired | Yes | No | ‐ | ‐ | Variable | Normal | Normal |
Methemoglobinemia, type I | Autosomal recessive |
Yes since birth |
No | ‐ | CYB5R3 | 20–30 | Decreased | Normal |
Methemoglobinemia, type II | Autosomal recessive |
Yes since birth |
No | Neurological involvement | CYB5R3 | 8–40 | Decreased | Normal |
Methemoglobinemia, type IV | Autosomal recessive | Yes | No |
46,XY DSD Ambiguous genitalia |
CYB5A | 12–19 | Normal | Normal |
HbM disease | Autosomal dominant |
Yes since birth or after HbF/A switching |
Yes | ‐ | HBA1, HBA2, HBB, HBG1, HBG2 | 12–25 | Normal | Abnormal |
Unstable Hb | Autosomal dominant | Yes | Yes | ‐ | HBA1, HBA2, HBB, HBG1, HBG2 | Variable (Stressor induced) | Normal |
N or Abnormal |
Abbreviation: DSD, disorder of sexual differentiation.